Ivermectina un medicamento de uso indiscriminado en el manejo del Covid-19

Vista sencilla de ítem
dc.contributor.authorAmaya Aponte, Silvia Camila
dc.date.accessioned2024-07-25T21:12:35Z
dc.date.available2024-07-25T21:12:35Z
dc.date.issued2021-08-20
dc.format.mimetypeapplication/pdfspa
dc.identifier.doihttps://doi.org/10.29375/01237047.4195
dc.identifier.instnameinstname:Universidad Autónoma de Bucaramanga UNABspa
dc.identifier.issni-ISSN 0123-7047spa
dc.identifier.issne-ISSN 2382-4603spa
dc.identifier.reponamereponame:Repositorio Institucional UNABspa
dc.identifier.repourlrepourl:https://repository.unab.edu.cospa
dc.identifier.urihttp://hdl.handle.net/20.500.12749/25740
dc.language.isospaspa
dc.publisher.facultyFacultad Ciencias de la Saludspa
dc.publisher.grantorUniversidad Autónoma de Bucaramanga UNABspa
dc.relationhttps://revistas.unab.edu.co/index.php/medunab/article/view/4195/3446spa
dc.relation.referencesChan JFW, Yuan S, Kok KH, To KKW, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-toperson transmission: a study of a family cluster. Lancet [Internet]. 2020;395(10223):514–23. doi: http://dx.doi. org/10.1016/S0140-6736(20)30154-9
dc.relation.referencesMeyerowitz EA, Richterman A, Gandhi RT, Sax PE. Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors. Ann Intern Med [Internet]. 2021;174(1):69–79. doi: https://doi. org/10.7326/M20-5008
dc.relation.referencesZemkova H, Tvrdonova V, Bhattacharya A, Jindrichova M. Allosteric modulation of ligand gated ion channels by ivermectin. Vol. 63, Physiological Research. 2014. doi: https://doi.org/10.33549/physiolres.932711
dc.relation.referencesBanerjee K, Nandy M, Dalai CK, Ahmed SN. The Battle against COVID 19 Pandemic: What we Need to Know Before we “Test Fire” Ivermectin. Drug Res (Stuttg). 2020;70(8):337-340. doi: https://doi. org/10.1055/a-1185-8913
dc.relation.referencesInstituto Nacional de Vigilancia de Medicamentos y Alimentos - INVIMA. Sistema de Trámites en Línea - Consultas Públicas. 2017. :8082. Available from: http://consultaregistro.invima.gov.co:8082/Consultas/ consultas/consreg_encabcum.jsp
dc.relation.referencesSchmith VD, Zhou J, Lohmer LRL. The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID-19. Clin Pharmacol Ther [Internet]. 2020;108(4):762–5. doi: https://doi. org/10.1002/cpt.1889
dc.relation.referencesCaly L, Druce JD, Catton MG, Jans DA, Wagsta KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Research 178, 104787. Antiviral Res [Internet]. 2020;178(January):104787. doi: https://doi.org/10.1016/j. antiviral.2020.104787
dc.relation.referencesRajter JC, Sherman MS, Fatteh N, Vogel F, Sacks J, Rajter JJ. ICON (Ivermectin in COvid Nineteen) study: Use of Ivermectin is Associated with Lower Mortality in Hospitalized Patients with COVID19. medRxiv [Internet]. 2020;(January). doi: https://doi. org/10.1101/2020.06.06.20124461
dc.relation.referencesOrtega-Guillén E, Meneses G, Coila E. Remarks About Retrospective Analysis of Ivermectin Effectiveness on Coronavirus Disease 2019 (ICON Study). CHEST J [Internet]. 2020;159(1):2110–1. doi: https://doi. org/10.1016/j.chest.2020.10.088
dc.relation.referencesAhmed S, Karim MM, Ross AG, Hossain MS, Clemens JD, Sumiya MK, et al. A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness. Int J Infect Dis. 2021;103:214– 6. doi: https://doi.org/10.1016/j.ijid.2020.11.191
dc.relation.referencesCamprubí D, Almuedo-Riera A, Martí-Soler HI, Soriano A, Hurtado JC, Subirà C, et al. Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients. PLoS One. 2020;15(11 November):1–6. doi: https://doi.org/10.1371/journal.pone.0242184
dc.relation.referencesBehera P, Patro BK, Singh AK, Chandanshive PD, Ravikumar SR, Pradhan SK, et al. Role of ivermectin in the prevention of SARSCoV-2 infection among healthcare workers in India: A matched case-control study. PLoS One [Internet]. 2021;16(2 February):1–12. Available from: http://dx.doi.org/10.1371/journal. pone.0247163
dc.relation.referencesLópez-Medina E, López P, Hurtado IC, Dávalos DM, Ramirez O, Martínez E, et al. Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19 A Randomized Clinical Trial Visual Abstract Supplemental content. JAMA [Internet]. 2021;325(14):1426–35. Available from: https:// jamanetwork.com/
dc.relation.referencesBuonfrate D, Bisoffi Z. Standard Dose Ivermectin for COVID-19. Chest [Internet]. 2021;159(5):2111–2. doi: https://doi.org/10.1016/j.chest.2021.03.003
dc.relation.referencesZangrillo A. COVID-19 y Argumentum ad ignorantiam o «no todo vale». Rev Clínica Española [Internet]. 2020;10(January):19–21. doi: https://doi.org/10.1016/j. rce.2020.04.013
dc.relation.urihttps://revistas.unab.edu.co/index.php/medunab/issue/view/275spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.creativecommonsAtribución-NoComercial-SinDerivadas 2.5 Colombia*
dc.rights.localAbierto (Texto Completo)spa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.sourceVol. 24 Núm. 2 (2021): agosto-noviembre, 2021: Telemedicina, Neoplasias, Cannabis; 151-154spa
dc.subjectIvermectinaspa
dc.subjectMedicamentospa
dc.subjectPatógenosspa
dc.subjectInfeccionesspa
dc.subject.keywordsMedical scienceseng
dc.subject.keywordsLife scienceseng
dc.subject.keywordsIvermectineng
dc.subject.keywordsMedicationeng
dc.subject.keywordsPathogenseng
dc.subject.keywordsInfectionseng
dc.subject.keywordsIvermectinapor
dc.subject.keywordsMedicamentospor
dc.subject.keywordsPatógenospor
dc.subject.keywordsInfecçõespor
dc.subject.keywordsMedical scienceseng
dc.subject.keywordsLife scienceseng
dc.subject.keywordsHealth scienceseng
dc.subject.keywordsCiências médicaspor
dc.subject.keywordsCiências da vidapor
dc.subject.keywordsCiências da saúdepor
dc.subject.lembCiencias médicasspa
dc.subject.lembCiencias de la vidaspa
dc.subject.proposalCiencias de la saludspa
dc.titleIvermectina un medicamento de uso indiscriminado en el manejo del Covid-19spa
dc.title.translatedIvermectin a drug of indiscriminate use in the management of Covid-19eng
dc.title.translatedIvermectina, uma droga de uso indiscriminado no manejo da Covid-19por
dc.typeArticleeng
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aaspa
dc.type.driverinfo:eu-repo/semantics/article
dc.type.hasversioninfo:eu-repo/semantics/publishedVersion
dc.type.localArtículospa
dc.type.redcolhttp://purl.org/redcol/resource_type/ART

Archivos

Bloque original

Mostrando 1 - 1 de 1
Miniatura
Nombre:
Artículo.pdf
Tamaño:
521.77 KB
Formato:
Adobe Portable Document Format
Descripción:
Artículo
Descargar

Bloque de licencias

Mostrando 1 - 1 de 1
Miniatura
Nombre:
license.txt
Tamaño:
183 B
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Revista MedUNAB